Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
Full metadata record
|dc.identifier.citation||Climacteric, 2012; 15(3):213-216||en|
|dc.description.abstract||The quality of life of countless menopausal women world-wide has been signifi cantly diminished following the sensationalist reporting of the Women’s Health Initiative (WHI) and the resulting 50% or more decline in the use of hormone replacement therapy (HRT) over the subsequent 10 years. Quality of life is difficult to measure as there are so many contributing factors and a large number of different instruments, some of which assess general health and only a few which specifi cally include symptoms related to menopause. HRT improves quality of life of symptomatic menopausal women and some studies of the effects of HRT provide reliable evidence on quality of life other than reduction in vasomotor symptoms. Until there is a better understanding of the minimal risks of HRT for the majority of women, too many will continue to suffer a reduced quality of life unnecessarily.||en|
|dc.description.statementofresponsibility||A. Pines, D.W. Sturdee and A.H. MacLennan||en|
|dc.publisher||Parthenon Publishing Group||en|
|dc.rights||© 2012 International Menopause Society||en|
|dc.subject||Quality of life; Women's Health Initiative; stopping HRT||en|
|dc.title||Quality of life and the role of menopausal hormone therapy||en|
|pubs.library.collection||Obstetrics and Gynaecology publications||en|
|Appears in Collections:||Obstetrics and Gynaecology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.